Ocrelizumab, edaravone, and valbenazine

Daniel A. Hussar; Terra Hussar

doi:10.1016/j.japh.2017.06.008

Ocrelizumab, edaravone, and valbenazine

Daniel A. Hussar, Terra Hussar

Department of Neurology

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	551-554
Number of pages	4
Journal	Journal of the American Pharmacists Association
Volume	57
Issue number	4
DOIs	https://doi.org/10.1016/j.japh.2017.06.008
State	Published - Jul 1 2017

All Science Journal Classification (ASJC) codes

Pharmacology (nursing)
Pharmacy
Pharmacology

Access to Document

10.1016/j.japh.2017.06.008

Cite this

@article{c6e0c2f1c02b42af828c2737f5ea29b6,

title = "Ocrelizumab, edaravone, and valbenazine",

author = "Hussar, {Daniel A.} and Terra Hussar",

year = "2017",

month = jul,

day = "1",

doi = "10.1016/j.japh.2017.06.008",

language = "English (US)",

volume = "57",

pages = "551--554",

journal = "Journal of the American Pharmaceutical Association. American Pharmaceutical Association",

issn = "1544-3191",

publisher = "American Pharmacists Association",

number = "4",

}

TY - JOUR

T1 - Ocrelizumab, edaravone, and valbenazine

AU - Hussar, Daniel A.

AU - Hussar, Terra

PY - 2017/7/1

Y1 - 2017/7/1

UR - http://www.scopus.com/inward/record.url?scp=85023615323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85023615323&partnerID=8YFLogxK

U2 - 10.1016/j.japh.2017.06.008

DO - 10.1016/j.japh.2017.06.008

M3 - Article

C2 - 28712464

AN - SCOPUS:85023615323

SN - 1544-3191

VL - 57

SP - 551

EP - 554

JO - Journal of the American Pharmaceutical Association. American Pharmaceutical Association

JF - Journal of the American Pharmaceutical Association. American Pharmaceutical Association

IS - 4

ER -

Ocrelizumab, edaravone, and valbenazine

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this